top of page

July 2022

Everads Therapy announced today that Israel’s Innovation Authority (IIA) has awarded a grant to help fund the company’s research and development. Moshe Weinstein, Everads’ CEO, stated that “We are excited to have been awarded this competitive grant, the receipt of which is a validation of the strong business and scientific case for our technology and pipeline. The grant programs of the Israel Innovation Authority are a true catalyst for Israeli companies, and we are honored and humbled to have been chosen.”


bottom of page